151 related articles for article (PubMed ID: 18157016)
21. Physiological concentrations of transforming growth factor beta1 selectively inhibit human dendritic cell function.
Fogel-Petrovic M; Long JA; Misso NL; Foster PS; Bhoola KD; Thompson PJ
Int Immunopharmacol; 2007 Dec; 7(14):1924-33. PubMed ID: 18039529
[TBL] [Abstract][Full Text] [Related]
22. CD40 ligand-triggered human dendritic cells mount interleukin-23 responses that are further enhanced by danger signals.
Sender LY; Gibbert K; Suezer Y; Radeke HH; Kalinke U; Waibler Z
Mol Immunol; 2010 Mar; 47(6):1255-61. PubMed ID: 20071030
[TBL] [Abstract][Full Text] [Related]
23. Differential activation of dendritic cells by nerve growth factor and brain-derived neurotrophic factor.
Noga O; Peiser M; Altenähr M; Knieling H; Wanner R; Hanf G; Grosse R; Suttorp N
Clin Exp Allergy; 2007 Nov; 37(11):1701-8. PubMed ID: 17892512
[TBL] [Abstract][Full Text] [Related]
24. CD40L stimulation of rat dendritic cells specifically favors the IL-12/IL-10 ratio resulting in a strong T cell stimulatory capacity.
Stax AM; Crul C; Kamerling SW; Schlagwein N; van der Geest RN; Woltman AM; van Kooten C
Mol Immunol; 2008 May; 45(9):2641-50. PubMed ID: 18262271
[TBL] [Abstract][Full Text] [Related]
25. CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.
Wong KL; Tang LF; Lew FC; Wong HS; Chua YL; MacAry PA; Kemeny DM
J Immunol; 2009 Jul; 183(1):41-50. PubMed ID: 19535645
[TBL] [Abstract][Full Text] [Related]
26. Experimental production of clinical-grade dendritic cell vaccine for acute myeloid leukemia.
Tan YF; Sim GC; Habsah A; Leong CF; Cheong SK
Malays J Pathol; 2008 Dec; 30(2):73-9. PubMed ID: 19291915
[TBL] [Abstract][Full Text] [Related]
27. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
You J; Wang CL; Hao XS
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273
[TBL] [Abstract][Full Text] [Related]
28. Dendritic cells derived from TBP-2-deficient mice are defective in inducing T cell responses.
Son A; Nakamura H; Okuyama H; Oka S; Yoshihara E; Liu W; Matsuo Y; Kondo N; Masutani H; Ishii Y; Iyoda T; Inaba K; Yodoi J
Eur J Immunol; 2008 May; 38(5):1358-67. PubMed ID: 18425727
[TBL] [Abstract][Full Text] [Related]
29. CD40 ligation during dendritic cell maturation reduces cell death and prevents interleukin-10-induced regression to macrophage-like monocytes.
Haenssle H; Buhl T; Knudsen S; Krueger U; Rosenberger A; Reich K; Neumann C
Exp Dermatol; 2008 Mar; 17(3):177-87. PubMed ID: 18081852
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cell maturation with poly(I:C)-based versus PGE2-based cytokine combinations results in differential functional characteristics relevant to clinical application.
Möller I; Michel K; Frech N; Burger M; Pfeifer D; Frommolt P; Veelken H; Thomas-Kaskel AK
J Immunother; 2008 Jun; 31(5):506-19. PubMed ID: 18463533
[TBL] [Abstract][Full Text] [Related]
31. Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity.
Balkow S; Loser K; Krummen M; Higuchi T; Rothoeft T; Apelt J; Tuettenberg A; Weishaupt C; Beissert S; Grabbe S
Exp Dermatol; 2009 Jan; 18(1):78-87. PubMed ID: 19054060
[TBL] [Abstract][Full Text] [Related]
32. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
[TBL] [Abstract][Full Text] [Related]
33. CD40L-expressing CD8 T cells prime CD8alpha(+) DC for IL-12p70 production.
Wong KL; Lew FC; MacAry PA; Kemeny DM
Eur J Immunol; 2008 Aug; 38(8):2251-62. PubMed ID: 18600823
[TBL] [Abstract][Full Text] [Related]
34. Immune properties of recombinant vaccinia virus encoding CD154 (CD40L) are determined by expression of virally encoded CD40L and the presence of CD40L protein in viral particles.
Bereta M; Bereta J; Park J; Medina F; Kwak H; Kaufman HL
Cancer Gene Ther; 2004 Dec; 11(12):808-18. PubMed ID: 15359290
[TBL] [Abstract][Full Text] [Related]
35. IFN-y enhances T(H)1 polarisation of monocyte-derived dendritic cells matured with clinical-grade cytokines using serum-free conditions.
Hildenbrand B; Lorenzen D; Sauer B; Hertkorn C; Freudenberg MA; Peters JH; Nesselhut T; Unger C; Azemar M
Anticancer Res; 2008; 28(3A):1467-76. PubMed ID: 18630500
[TBL] [Abstract][Full Text] [Related]
36. Unilineage monocytopoiesis in hematopoietic progenitor culture: switching cytokine treatment at all Mo developmental stages induces differentiation into dendritic cells.
Montesoro E; Castelli G; Morsilli O; Nisini R; Stafsnes MH; Carè A; Peschle C; Chelucci C
Cell Death Differ; 2006 Feb; 13(2):250-9. PubMed ID: 16110321
[TBL] [Abstract][Full Text] [Related]
37. Clinical grade OK432-activated dendritic cells: in vitro characterization and tracking during intralymphatic delivery.
West E; Morgan R; Scott K; Merrick A; Lubenko A; Pawson D; Selby P; Hatfield P; Prestwich R; Fraser S; Eves D; Anthoney A; Twelves C; Beirne D; Patel P; O'Donnell D; Watt S; Waller M; Dietz A; Robinson P; Melcher A
J Immunother; 2009 Jan; 32(1):66-78. PubMed ID: 19307995
[TBL] [Abstract][Full Text] [Related]
38. Comparative effects of aspirin and NO-releasing aspirins on differentiation, maturation and function of human monocyte-derived dendritic cells in vitro.
Bufan B; Mojsilović S; Vucićević D; Vucević D; Vasilijić S; Balint B; Colić M
Int Immunopharmacol; 2009 Jul; 9(7-8):910-7. PubMed ID: 19341823
[TBL] [Abstract][Full Text] [Related]
39. IL-4-mediated fine tuning of IL-12p70 production by human DC.
Guenova E; Volz T; Sauer K; Kaesler S; Müller MR; Wölbing F; Chen K; Schwärzler C; Brossart P; Röcken M; Biedermann T
Eur J Immunol; 2008 Nov; 38(11):3138-49. PubMed ID: 18924208
[TBL] [Abstract][Full Text] [Related]
40. Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors.
Gulen D; Abe F; Maas S; Reed E; Cowan K; Pirruccello S; Wisecarver J; Warkentin P; Northam M; Turken O; Coskun U; Senesac J; Talmadge JE
Int Immunopharmacol; 2008 Dec; 8(13-14):1728-36. PubMed ID: 18793758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
